Cargando…

Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance

BACKGROUND: Incretin-based therapies are rapidly becoming one of the main glycemic control strategies in diabetes. Considering the large numbers of papillary thyroid carcinomas (PTCs) and possible effects of glucagon-like peptide-1 (GLP-1) on cell proliferation, the expression of GLP-1 receptor (GLP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jung, Min Jung, Kwon, Su Kyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Endocrine Society 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4285044/ https://www.ncbi.nlm.nih.gov/pubmed/25559577 http://dx.doi.org/10.3803/EnM.2014.29.4.536

Ejemplares similares

Response: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.)
por: Jung, Min Jung, et al.
Publicado: (2015)

Letter: Expression of Glucagon-Like Peptide-1 Receptor in Papillary Thyroid Carcinoma and Its Clinicopathologic Significance (Endocrinol Metab 2014;29:536-44, Min Jung Jung et al.)
por: Park, Daeyoon, et al.
Publicado: (2015)

The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
por: Tang, Jingdong, et al.
Publicado: (2018)

Clinicopathological Significance of Minimal Extrathyroid Extension in Solitary Papillary Thyroid Carcinomas
por: Woo, Chang Gok, et al.
Publicado: (2015)

Effects of insulin analogs and glucagon-like peptide-1 receptor agonists on proliferation and cellular energy metabolism in papillary thyroid cancer
por: He, Liang, et al.
Publicado: (2017)

RET EXPRESSION AND ITS CORRELATION WITH CLINICOPATHOLOGIC DATA IN PAPILLARY THYROID CARCINOMA
por: Punda, Ante, et al.
Publicado: (2018)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
por: Kang, Yu Mi, et al.
Publicado: (2016)

Clinicopathological features of papillary thyroid carcinoma in HIV-infected patients
por: Liu, Jia, et al.
Publicado: (2023)

Association of Toll-Like Receptor 2 Polymorphisms with Papillary Thyroid Cancer and Clinicopathologic Features in a Korean Population
por: Kim, Mi Kyeong, et al.
Publicado: (2012)

Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells
por: Jeon, Yun Kyung, et al.
Publicado: (2014)

Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?
por: Lisco, Giuseppe, et al.
Publicado: (2023)

Computational Peptide Design Cotargeting Glucagon and Glucagon-like Peptide-1 Receptors
por: Vishnoi, Shubham, et al.
Publicado: (2023)

Clinicopathologic Differences Between Micropapillary and Papillary Thyroid Carcinoma
por: Kartal, Kinyas, et al.
Publicado: (2019)

Clinicopathological and Prognostic Significance of WW Domain Binding Protein 5 Expression in Papillary Thyroid Carcinoma
por: Qian, Yangyang, et al.
Publicado: (2019)

Ultrasound and clinicopathological features of papillary thyroid carcinomas with BRAF and TERT promoter mutations
por: Hahn, Soo Yeon, et al.
Publicado: (2017)

Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor
por: Underwood, Christina Rye, et al.
Publicado: (2010)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
por: Lee, Seungah, et al.
Publicado: (2017)

RET/PTC and CK19 Expression in Papillary Thyroid Carcinoma and Its Clinicopathologic Correlation
por: Shin, Eunah, et al.
Publicado: (2005)

Immunohistochemical Evaluation of β-Catenin Marker in Papillary Thyroid Cancer: Clinicopathologic Significance
por: Ziari, Katayoun, et al.
Publicado: (2018)

Clinicopathologic characteristics of familial versus sporadic papillary thyroid carcinoma
por: JIWANG, L., et al.
Publicado: (2015)

Clinicopathologic characteristics and outcomes of papillary thyroid carcinoma in younger patients
por: Lu, Yi, et al.
Publicado: (2020)

Clinicopathological Features of Low-Grade Thyroid-like Nasopharyngeal Papillary Adenocarcinoma
por: Li, Minhua, et al.
Publicado: (2017)

Vitamin D Receptor Expression and its Clinical Significance in Papillary Thyroid Cancer
por: Kim, Min Jhi, et al.
Publicado: (2022)

Classic Papillary Thyroid Carcinoma with Tall Cell Features and Tall Cell Variant Have Similar Clinicopathologic Features
por: Oh, Woo Jin, et al.
Publicado: (2014)

Papillary thyroid carcinoma variants with tall columnar cells
por: Jung, Chan Kwon
Publicado: (2020)

Expression and Clinical Significance of Thyroid-stimulating hormone receptor in the Subtypes of Papillary thyroid carcinomas
por: Shen, Wei, et al.
Publicado: (2023)

A Review on the Association between Glucagon-Like Peptide-1 Receptor Agonists and Thyroid Cancer
por: Chiu, Wei-Yih, et al.
Publicado: (2012)

The Warthin-Like Variant of Papillary Thyroid Carcinoma: A Comparison with Classic Type in the Patients with Coexisting Hashimoto's Thyroiditis
por: Yeo, Min-kyung, et al.
Publicado: (2015)

Clinicopathological parameters for predicting non-invasive follicular thyroid neoplasm with papillary features (NIFTP)
por: Jang, Eunju, et al.
Publicado: (2021)

P2X(7) Receptor Expression in Coexistence of Papillary Thyroid Carcinoma with Hashimoto's Thyroiditis
por: Kwon, Ji Hyun, et al.
Publicado: (2014)

Glucagon-like Peptide-1 Receptor Analogues for the Treatment of Obesity
por: Williams, David M, et al.
Publicado: (2022)

Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma
por: Zhou, Yi-Li, et al.
Publicado: (2018)

Ultrasonographic Findings of Medullary Thyroid Carcinoma: a Comparison with Papillary Thyroid Carcinoma
por: Kim, Sung-Hun, et al.
Publicado: (2009)

Significance of Interleukin-6 in Papillary Thyroid Carcinoma
por: Kobawala, Toral P., et al.
Publicado: (2016)

Clinicopathological implications of leptin and leptin receptor expression in papillary thyroid cancer
por: ZHANG, GUO-AN, et al.
Publicado: (2013)

Is obesity associated with the prognosis of papillary thyroid carcinoma?
por: Kim, Jung Min
Publicado: (2022)

Equine glucagon-like peptide-1 receptor physiology
por: Kheder, Murad H., et al.
Publicado: (2018)

Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
por: Pocai, Alessandro, et al.
Publicado: (2009)

Papillary thyroid carcinoma: does the association with Hashimoto's thyroiditis affect the clinicopathological characteristics of the disease?()()
por: Girardi, Fábio Muradás, et al.
Publicado: (2014)

Clinicopathologic significance of the expression of Snail in hepatocellular carcinoma
por: Woo, Hyun Young, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_56tkh2gts6n8k552gc1b66nfpn